Breaking News

Thermo Fisher Scientific Completes MarqMetrix Acquisition

Expands Raman spectroscopy portfolio with in-line Process Analytical Technology.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fisher Scientific Inc. has completed its acquisition of MarqMetrix, a privately held developer of Raman-based spectroscopy solutions for in-line measurement. The terms of the deal were not disclosed.   Based in Seattle, WA, MarqMetrix provides innovative and fit-for-purpose in-line Process Analytical Technology (PAT), offering customers a simplified method to make precise and accurate measurements throughout the manufacturing process for a wide range of applications, including biopharma...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters